Literature DB >> 11949936

Phosphofructokinase deficiency; past, present and future.

Hiromu Nakajima1, Nina Raben, Tomoya Hamaguchi, Tomoyuki Yamasaki.   

Abstract

Phosphofructokinase deficiency (Tarui disease, glycogen storage disease VII, GSD VII) stands out among all the GSDs. PFK deficiency was the first recognized disorder that directly affects glycolysis. Ever since the discovery of the disease in 1965, a wide range of biochemical, physiological and molecular studies of the disorder have greatly expanded our understanding of the function of normal muscle, general control of glycolysis and glycogen metabolism. The studies of PFK deficiency vastly enriched the field of glycogen storage diseases, as well as the field of metabolic and neuromuscular disorders. This article cites a historical overview of this clinical entity and the progress that has been made in molecular genetic area. We will also present the results of a search in-silico, which allowed us to identify a previously unknown sequence of the human platelet PFK gene (PFK-P). In addition, we will describe phylogenetic analysis of evolution of PFK genes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11949936     DOI: 10.2174/1566524024605734

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  25 in total

1.  Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.

Authors:  Anna A DePaoli-Roach; Vincent S Tagliabracci; Dyann M Segvich; Catalina M Meyer; Jose M Irimia; Peter J Roach
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  DNA microarray analysis reveals differential gene expression in the soleus muscle between male and female rats exposed to a high fat diet.

Authors:  Tae Seok Oh; Jong Won Yun
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

3.  Unclassified polysaccharidosis of the heart and skeletal muscle in siblings.

Authors:  Benedikt Schoser; Claudio Bruno; Hans-Christian Schneider; Yoon S Shin; Teodor Podskarbi; Lev Goldfarb; Wolfgang Müller-Felber; Josef Müller-Höcker
Journal:  Mol Genet Metab       Date:  2008-08-08       Impact factor: 4.797

Review 4.  Glycogen metabolism and glycogen storage disorders.

Authors:  Shibani Kanungo; Kimberly Wells; Taylor Tribett; Areeg El-Gharbawy
Journal:  Ann Transl Med       Date:  2018-12

5.  Missense mutation in PFKM associated with muscle-type phosphofructokinase deficiency in the Wachtelhund dog.

Authors:  G Inal Gultekin; K Raj; S Lehman; A Hillström; U Giger
Journal:  Mol Cell Probes       Date:  2012-03-16       Impact factor: 2.365

Review 6.  Neuromuscular disorders of glycogen metabolism.

Authors:  Elisabetta Gazzerro; Antoni L Andreu; Claudio Bruno
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

7.  Non-targeted metabolomics of Brg1/Brm double-mutant cardiomyocytes reveals a novel role for SWI/SNF complexes in metabolic homeostasis.

Authors:  Ranjan Banerjee; Scott J Bultman; Darcy Holley; Carolyn Hillhouse; James R Bain; Christopher B Newgard; Michael J Muehlbauer; Monte S Willis
Journal:  Metabolomics       Date:  2015-10-01       Impact factor: 4.290

8.  Abnormal metabolism of glycogen phosphate as a cause for Lafora disease.

Authors:  Vincent S Tagliabracci; Jean Marie Girard; Dyann Segvich; Catalina Meyer; Julie Turnbull; Xiaochu Zhao; Berge A Minassian; Anna A Depaoli-Roach; Peter J Roach
Journal:  J Biol Chem       Date:  2008-10-13       Impact factor: 5.157

Review 9.  Tarui disease and distal glycogenoses: clinical and genetic update.

Authors:  A Toscano; O Musumeci
Journal:  Acta Myol       Date:  2007-10

10.  Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis.

Authors:  Miguel García; Anna Pujol; Albert Ruzo; Efrén Riu; Jesús Ruberte; Anna Arbós; Anna Serafín; Beatriz Albella; Juan Emilio Felíu; Fátima Bosch
Journal:  PLoS Genet       Date:  2009-08-21       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.